These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15226147)
1. Geographic location of commercial plasma donation clinics in the United States, 1980-1995. James RC; Mustard CA Am J Public Health; 2004 Jul; 94(7):1224-9. PubMed ID: 15226147 [TBL] [Abstract][Full Text] [Related]
2. Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system. Jacobson JO J Urban Health; 2006 Mar; 83(2):150-61. PubMed ID: 16736365 [TBL] [Abstract][Full Text] [Related]
3. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule. Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337 [TBL] [Abstract][Full Text] [Related]
4. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L; AbdulRahman M; John TJ; AlHashimi A Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Offergeld R; Faensen D; Ritter S; Hamouda O Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310 [TBL] [Abstract][Full Text] [Related]
6. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP; Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352 [TBL] [Abstract][Full Text] [Related]
7. Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. Burke-Miller JK; Weber K; Cohn SE; Hershow RC; Sha BE; French AL; Cohen MH AIDS Care; 2016 Oct; 28(10):1274-9. PubMed ID: 27098593 [TBL] [Abstract][Full Text] [Related]
8. HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation. Dong R; Qiao X; Jia W; Wong M; Qian H; Zheng X; Xing W; Lai S; Wu Z; Jiang Y; Wang N Biomed Environ Sci; 2011 Jun; 24(3):207-13. PubMed ID: 21784304 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study. Mohammed Y; Bekele A BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241 [TBL] [Abstract][Full Text] [Related]
10. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal]. Koch C; Araújo F Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637 [TBL] [Abstract][Full Text] [Related]
12. The Association Between Neighborhood Environment and Mortality: Results from a National Study of Veterans. Nelson K; Schwartz G; Hernandez S; Simonetti J; Curtis I; Fihn SD J Gen Intern Med; 2017 Apr; 32(4):416-422. PubMed ID: 27815763 [TBL] [Abstract][Full Text] [Related]
13. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011]. Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran. Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560 [TBL] [Abstract][Full Text] [Related]
15. The development of a standardized neighborhood deprivation index. Messer LC; Laraia BA; Kaufman JS; Eyster J; Holzman C; Culhane J; Elo I; Burke JG; O'Campo P J Urban Health; 2006 Nov; 83(6):1041-62. PubMed ID: 17031568 [TBL] [Abstract][Full Text] [Related]
16. Romanian blood donors screening: is it really necessary and/or mandatory? Hâţu G; Brumboiu MI; Gorgan IN; Bocşan IS Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):741-6. PubMed ID: 24502043 [TBL] [Abstract][Full Text] [Related]
17. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. Li M; Li R; Shen Z; Li C; Liang N; Peng Z; Huang W; He C; Zhong F; Tang X; Lan G BMC Public Health; 2017 Sep; 17(1):759. PubMed ID: 28962612 [TBL] [Abstract][Full Text] [Related]
18. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858 [TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of markers of transfusion transmissible infections in blood bank in Colombia]. Bedoya JA; Cortés Márquez MM; Cardona Arias JA Rev Saude Publica; 2012 Dec; 46(6):950-9. PubMed ID: 23503536 [TBL] [Abstract][Full Text] [Related]
20. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]